Spots Global Cancer Trial Database for hepatitis b virus reactivation
Every month we try and update this database with for hepatitis b virus reactivation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide | NCT03804372 | Large-B-cell Di... Chronic Lymphoi... | Rituximab Chemotherapy Tenofovir alafe... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide | NCT03804372 | Large-B-cell Di... Chronic Lymphoi... | Rituximab Chemotherapy Tenofovir alafe... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP | NCT01210287 | Lymphoma | nucleoside anal... | 18 Years - 75 Years | Fudan University |